| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/22/2009 | EP2049113A2 Medicament for the enhancement of cognitive function and neuroprotection |
| 04/22/2009 | EP2049097A2 Composition and method for binding acetaldehyde in stomach |
| 04/22/2009 | EP2049095A2 Milnacipran for the treatment of fatigue associated with fibromyalgia syndrome |
| 04/22/2009 | EP2049094A2 Milnacipran for the treatment of cognitive dysfunction associated with fibromyalgia |
| 04/22/2009 | EP2049093A2 Pharmaceutical composition containing saredutant and a selective inhibitor of serotonin recapture or an inhibitor of serotonin/norepinephrine recapture in combination |
| 04/22/2009 | EP2049087A2 Hydrophilic abuse deterrent delivery system |
| 04/22/2009 | EP2002832A9 Composition containing lignan compound |
| 04/22/2009 | EP1893608A4 Thiazolyl mglur5 antagonists and methods for their use |
| 04/22/2009 | EP1815853B1 Therapeutic agent ((-)-bpap) for drug dependence |
| 04/22/2009 | EP1549305B1 Alpha 2b 0r 2b/2c adrenoceptor agonists for the treatment of morbus alzheimer and morbus parkinson |
| 04/22/2009 | EP1507529B1 Combination comprising valsartan, amlodipine and hydrochlorothiazide |
| 04/22/2009 | EP1505974B1 Use of compounds that are effective as selective opiate receptor modulators |
| 04/22/2009 | EP1364069B1 Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylatoin status of the genes |
| 04/22/2009 | CN101415729A Antibodies against amyloid-beta peptide |
| 04/22/2009 | CN101415713A Novel spiro [imidazolidine-4, 3' -indole] 2, 2', 5' (1H) triones for treatment of conditions associated with vanilloid receptor 1 |
| 04/22/2009 | CN101415712A Use of spiro imidazolidine-4, 3'-indole-2, 2', 5' (1H) triones for treatment of conditions associated with vanilloid receptor 1 |
| 04/22/2009 | CN101415711A Novel spiro [imidazolidine-4, 3 '-indole] 2,2', 5' (1'H) triones for treatment of conditions associated with vanilloid receptor 1 |
| 04/22/2009 | CN101415690A Novel tricyclic dihydropyrazines as potassium channel openers |
| 04/22/2009 | CN101415680A Benzoisoindole derivatives for the treatment of pain |
| 04/22/2009 | CN101415678A Benzo[F]isoindol-2-ylphenyl acetic acid derivatives as EP4 receptor agonists |
| 04/22/2009 | CN101415464A Solid oral compositions based on s-adenosyl methionine and/or NADH and process for obtaining them |
| 04/22/2009 | CN101415435A Amylin and amylin agonists for treating psychiatric diseases and disorders |
| 04/22/2009 | CN101415418A Agent exhibiting a neurotropic, neuromodulator, cerebrovascular and anti- stroke activity |
| 04/22/2009 | CN101413143A Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 04/22/2009 | CN101412959A Medical liquor |
| 04/22/2009 | CN101412708A Duloxetine derivative and preparation thereof |
| 04/22/2009 | CN101412707A Duloxetine derivative and preparation thereof |
| 04/22/2009 | CN101412678A Method for synthesizing memantine hydrochloride |
| 04/22/2009 | CN101411876A Neurotoxic oligomers |
| 04/22/2009 | CN101411858A Medicament for alcoholic intoxication |
| 04/22/2009 | CN101411853A Health care medical pillow for strengthening brain and inducing resuscitation |
| 04/22/2009 | CN101411845A Cancer-suppressing analgesic medicament |
| 04/22/2009 | CN101411833A Dragon's blood extract as well as preparation method and application thereof |
| 04/22/2009 | CN101411823A Medicinal granules for preventing optic atrophy of old age |
| 04/22/2009 | CN101411800A Medicament for treating anxiety symptoms |
| 04/22/2009 | CN101411798A Chinese medicine preparation for treating schizophrenia |
| 04/22/2009 | CN101411783A Method for preparing paste for nourishing kidney |
| 04/22/2009 | CN101411758A Chinese medicine solid formulation for treating insomnia and preparation method thereof |
| 04/22/2009 | CN101411753A Broomrape extract, broomrape total glycosides, broomrape polysaccharide as well as preparation method and application thereof |
| 04/22/2009 | CN101411741A Medicament for treating psychosis |
| 04/22/2009 | CN101411731A Hypericuin perforatum L. extract and preparation method thereof |
| 04/22/2009 | CN101411716A Use of polygonin for preparing product for resisting dementia |
| 04/22/2009 | CN101411713A Compound Nimodipine tablet, and enteric tablet thereof, as well as preparation method thereof |
| 04/22/2009 | CN101411712A 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia |
| 04/22/2009 | CN101411700A Use of 5,7,4'-trihydroxy flavanone or derivative thereof for analgesia |
| 04/22/2009 | CN101411494A Corn peptide beverage for sobering-up and preparation method thereof |
| 04/22/2009 | CN100480387C GBS toxin receptor |
| 04/22/2009 | CN100480375C Human cord blood derived unrestricted somatic stem cells (USSC) |
| 04/22/2009 | CN100480269C Anti-vegf antibodies |
| 04/22/2009 | CN100480253C Alkylamino alkoxyl substituted C-glycosylisoflavones and preparing method and the use of the same |
| 04/22/2009 | CN100480242C CDK-inhibitory pyrimidines, and production and use thereof as pharmaceutical agents |
| 04/22/2009 | CN100479862C Transporters and drug delivery system by using the same |
| 04/22/2009 | CN100479837C Weinakang for treating ischemic cerebrovascular disease and senile dementia and preparation method thereof |
| 04/22/2009 | CN100479833C Extraction method of polygala refined total saponin |
| 04/22/2009 | CN100479822C Clozapine encapsulated solid lipid microparticle and preparation process thereof |
| 04/22/2009 | CN100479816C Gingko total terpene lactone compounded medicinal composition, and preparing method and use thereof |
| 04/22/2009 | CN100479812C A microemulsion preparation of high concentration propofol for anesthetic uses |
| 04/22/2009 | CN100479805C Chinese caterpillar fungus injection preparation method |
| 04/21/2009 | US7521481 administering to subject a pharmaceutically effective amount of inositol stereoisomers, enantiomers or derivatives thereof; for treating or preventing condition of central or peripheral nervous system or systemic organ associated with a disorder in protein folding or aggregation, or amyloid formation |
| 04/21/2009 | US7521479 Administering chaotropic agent |
| 04/21/2009 | US7521471 CB1cannabinoid receptor antagonists; e.g. 5-(4-chlorophenyl)-4-cyano-1-(2,4-dichlorophenyl)-N-piperidin-1-yl-1H-pyrazole-3-carboxamide; various psychological, neurodegenerative, pain and cardiovascular disorders |
| 04/21/2009 | US7521464 drugs have beta-amyloid peptide production inhibitory activity, such as 2-(2-benzo[b]thiophen-4-yl-acetylamino)-N-(5-phenyl-2H-pyrazol-3-yl)-propionamide, useful for treatment of Alzheimer's disease and Down's Syndrome |
| 04/21/2009 | US7521455 Histamine H3 receptor antagonist or inverse agonist activity; metabolic diseases, circulatory diseases, or nervous system diseases; e.g. 3-(4-((1-cyclobutyl-4-piperidinyl)oxy)phenyl)-2-ethylpyrido(2,3-d)pyrimidin-4(3H)-one |
| 04/21/2009 | US7521451 e.g. 5,6-dimethyl-3a,4,7,7a-tetrahydro-2-benzofuran-1,3-dione;intravenous, water-soluble compounds useful for manufacturing an anasthetic, sedative agents; side effect reduction |
| 04/21/2009 | US7521450 Inhibitors of kinases |
| 04/21/2009 | US7521445 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
| 04/21/2009 | US7521438 Allergies,chronic obstructive airway disorders (COPD), e.g. bronchial asthma, chronic obstructive bronchitis, pulmonary emphysema with reversible obstruction, bronchial asthma and other bronchial disorders; side effect reduction |
| 04/21/2009 | US7521212 Method for producing oligopolysaccharides |
| 04/21/2009 | US7521070 Powder of ossified horns of reindeer and containing endorphins in the form of agent for preventing and treating pathological states associated with endorphin deficiency; drug abuse, drug dependence |
| 04/21/2009 | US7521068 For pulmonary and nasal drug administration |
| 04/21/2009 | CA2400317C Improved paste formulations |
| 04/21/2009 | CA2362003C Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 04/21/2009 | CA2356263C Aminopyrazole derivatives |
| 04/21/2009 | CA2336902C Topical compositions comprising an opioid analgesic and an nmda antagonist |
| 04/21/2009 | CA2320878C Morphine sulphate microgranules, method for making same and pharmaceutical preparations |
| 04/21/2009 | CA2279184C Pharmaceutical compositions containing ibuprofen and domperidone for the treatment of migraine |
| 04/16/2009 | WO2009049233A1 Method for treating and/or preventing drug seeking behavior |
| 04/16/2009 | WO2009048864A1 Solid forms of (s)-2-amino-3-(4-(2-amino-6-((r)-2,2,2-trifluoro-1-(3'-methoxybiphenyl-4-yl)ethoxy)pyrimidin-4-yl)phenyl)propanoic acid and methods of their use |
| 04/16/2009 | WO2009048765A1 5-ht7 receptor antagonists |
| 04/16/2009 | WO2009048101A1 Amide compound |
| 04/16/2009 | WO2009047935A1 Fine particles |
| 04/16/2009 | WO2009047779A2 Composition containing fentanyl base aromatic oils and alkyl salicylate for the delivery of fentanyl base in vapour form |
| 04/16/2009 | WO2009047770A2 Cytoplasmic malate dehydrogenase (mdh1) targeted treatment for neurodegenerative diseases |
| 04/16/2009 | WO2009047723A2 Tetrahydroquinoline derivatives for treating post-traumatic stress disorders |
| 04/16/2009 | WO2009047359A1 Inhibitors of protein kinases |
| 04/16/2009 | WO2009047303A2 Metabotropic glutamate receptor modulators for the treatment of pervasive developmental disorder |
| 04/16/2009 | WO2009047296A2 Metabotropic glutamate receptor modulators for the treatment op parkinson's disease |
| 04/16/2009 | WO2009046881A1 Use of a peptide combination including c-peptide, as a therapeutic agent |
| 04/16/2009 | WO2009046880A2 Use of a peptide as a therapeutic agent |
| 04/16/2009 | WO2009046879A2 Use of the combination of npy and nociceptin as a therapeutic agent |
| 04/16/2009 | WO2009046878A1 Tnf inhibitory peptide and cgrp as therapeutic agents |
| 04/16/2009 | WO2009046877A2 Use of a histrelin and leuprolide as therapeutic agents |
| 04/16/2009 | WO2009046876A2 Use of a peptide as a therapeutic agent |
| 04/16/2009 | WO2009046875A2 Combination of splenopentin and thymopentin and the use thereof in medicine |
| 04/16/2009 | WO2009046874A1 Therapeutic combination of trh-potentiating peptide and stresscopin |
| 04/16/2009 | WO2009046873A1 Combined use of vasonatrin and gastrin-i as a therapeutic agent |
| 04/16/2009 | WO2009046872A2 Use of a peptide as a therapeutic agent |
| 04/16/2009 | WO2009046868A1 Use of a peptide as a therapeutic agent |
| 04/16/2009 | WO2009046867A2 Caerulein alone or in combination with acth (3-24 ) as therapeutic agent |
| 04/16/2009 | WO2009046866A2 Trap-14 as a therapeutic agent |